Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: OPTISON

« Back to Dashboard

Summary for Tradename: OPTISON

Patents:1
Applicants:1
NDAs:1
Suppliers: see list1

Pharmacology for Tradename: OPTISON

Clinical Trials for: OPTISON

A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice.
Status: Completed Condition: Echocardiography

CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children
Status: Recruiting Condition: Vesico-Ureteral Reflux

Regadenoson Real Time Perfusion Imaging Trial-Optison
Status: Recruiting Condition: Coronary Artery Disease; Myocardial Perfusion Abnormalities

Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease
Status: Terminated Condition: Carotid Artery Disease

Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR).
Status: Completed Condition: Pulmonary Hypertension

Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
Status: Completed Condition: Abdominal Neoplasms; Pelvic Neoplasms

Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage
Status: Not yet recruiting Condition: Atrial Fibrillation

Contrast-Enhanced Ultrasound in Human Crohn's Disease
Status: Not yet recruiting Condition: Crohn's Disease

Pre-operative Evaluation of Kidney & Pancreas Transplant Patients
Status: Active, not recruiting Condition: Kidney Transplantation; Pancreas Transplantation

Contrast Enhanced Ultrasound for Evaluation of Pediatric Abdominal Trauma
Status: Not yet recruiting Condition: Abdominal Trauma

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare
OPTISON
albumin human
INJECTABLE;INJECTION020899Dec 31, 1997RXYes6,723,303<disabled>Y<disabled>
Ge Healthcare
OPTISON
albumin human
INJECTABLE;INJECTION020899Dec 31, 1997RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc